文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

衰弱与荷兰老年住院COVID-19患者院内死亡相关:COVID-OLD研究

Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study.
PubMed 文献 · Age Ageing · 2021-01-01

该多中心回顾性队列研究纳入荷兰15家医院2020年2月至5月住院的≥70岁临床确诊COVID-19患者,共1376例,中位年龄78岁,60%为男性。院内死亡499例(38%)。多因素分析显示,临床衰弱量表(CFS)评分与院内死亡独立相关:与CFS 1-3相比,CFS 4-5的比值比(OR)为2.0(95%CI 1.3-3.0),CFS 6-9的OR为2.8(95%CI 1.8-4.3)。

要点

  • 老年住院COVID-19患者院内死亡率为38%。
  • 衰弱(CFS 6-9)患者合并症更多、症状持续时间更短、氧需求更低且CRP水平更低。
  • 校正后衰弱与院内死亡独立相关,CFS 4-5风险约2倍,CFS 6-9风险约3倍。

核心结论

  • 在荷兰老年住院COVID-19患者中,衰弱是院内死亡的独立危险因素。

研究设计与样本

  • 多中心回顾性队列研究,纳入荷兰15家医院2020年2月至5月住院的≥70岁临床确诊COVID-19患者,共1376例。

主要发现

  • 共499例(38%)患者院内死亡。
  • 衰弱(CFS 6-9)患者合并症更多、就诊时症状持续时间更短(中位4天 vs 7天)、氧需求更低且C反应蛋白水平更低。
  • 多因素分析显示,与CFS 1-3相比,CFS 4-5的院内死亡OR为2.0(95%CI 1.3-3.0),CFS 6-9的OR为2.8(95%CI 1.8-4.3)。

关键数值与推荐

  • 临床衰弱量表(CFS)评分用于评估衰弱,CFS 1-3为参照组,CFS 4-5和CFS 6-9为暴露组。
  • 主要结局为院内死亡。

临床怎么用

  • 对老年住院COVID-19患者应使用CFS评估衰弱状态以辅助预后判断。
  • 衰弱患者可能因症状不典型(如氧需求低、CRP低)而较早就诊,但仍需警惕较高死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, older patients had an increased risk of hospitalisation and death. Reports on the association of frailty with poor outcome have been conflicting. OBJECTIVE: The aim of the present study was to investigate the independent association between frailty and in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands. METHODS: This was a multicentre retrospective cohort study in 15 hospitals in the Netherlands, including all patients aged ≥70 years, who were hospitalised with clinically confirmed COVID-19 between February and May 2020. Data were collected on demographics, co-morbidity, disease severity and Clinical Frailty Scale (CFS). Primary outcome was in-hospital mortality. RESULTS: A total of 1,376 patients were included (median age 78 years (interquartile range 74-84), 60% male). In total, 499 (38%) patients died during hospital admission. Parameters indicating presence of frailty (CFS 6-9) were associated with more co-morbidities, shorter symptom duration upon presentation (median 4 versus 7 days), lower oxygen demand and lower levels of C-reactive protein. In multivariable analyses, the CFS was independently associated with in-hospital mortality: compared with patients with CFS 1-3, patients with CFS 4-5 had a two times higher risk (odds ratio (OR) 2.0 (95% confidence interval (CI) 1.3-3.0)) and patients with CFS 6-9 had a three times higher risk of in-hospital mortality (OR 2.8 (95% CI 1.8-4.3)). CONCLUSIONS: The in-hospital mortality of older hospitalised COVID-19 patients in the Netherlands was 38%. Frailty was independently associated with higher in-hospital mortality, even though COVID-19 patients with frailty presented earlier to the hospital with less severe symptoms.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Blomaard LC, van der Linden CMJ, van der Bol JM, et al. Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study. Age Ageing. 2021. PMID: 33951156. doi:10.1093/ageing/afab018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。